Since we observed that combining atRA with trastuzumab uniquely resulted in apoptosis, we examined the effects of other retinoids with trastuzumab, in both ER-positive (BT474) and ER-negative (SKBR3) HER2-overexpressing human breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.